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Background  and  purpose      Late  infections  after  total  hip 
arthroplasty are still a problem. Treatment procedures include 
resection  arthroplasty  with  implantation  of  antibiotic-loaded 
beads or implantation of an antibiotic-impreganted spacer. How-
ever, little is known about antibiotic elution from bone cement 
beyond the first 2–3 postoperative days in humans. 
Methods   17 hip spacers (80 g PMMA, 1 g gentamicin, and 
4 g vancomycin)  and  11  chains  (40 g PMMA,  0.5 g gentamicin, 
and 2 g vancomycin) in 28 patients were studied. The release of 
both agents was measured in the drainage fluid on a daily basis. 
The drains were left in situ until less than 50 mL was produced 
per day. The elution of both antibiotics was determined by fluo-
rescence  polarization  immunoassay.  Systemic  antibiotics  were 
given postoperatively according to antibiogram. If possible, no 
gentamicin or vancomycin was given.
Results      Peak  mean  concentrations  from  beads  and  spac-
ers were reached for gentamicin (1,160 (12-371) µg/mL and 21 
(0.7–39) µg/mL, respectively) and for vancomycin (80 (21–198) 
µg/mL and 37 (3.3–72) µg/mL) on day 1. The last concentrations 
to be determined were 3.7 µg/mL gentamicin and 23 µg/mL van-
comycin in the beads group after 13 days, and 1.9 µg/mL gen-
tamicin and 6.6 µg/mL vancomycin in the spacer group after 7 
days. Between the fifth and seventh day, an intermittent increase 
in elution of vancomycin from both beads and spacers and of gen-
tamicin from spacers was noticed. No renal or hepatic dysfunc-
tion was observed.
Interpretation   Beads showed higher elution characteristics in 
vivo than the spacers due to their larger surface area; however, a 
great amount of inter-subject variability was seen for both beads 
and spacers. The inferior elution properties of spacers emphasize 
the importance of additional systemic antibiotics for this treat-
ment procedure during the postoperative period. Future studies 
should clarify whether the dose of antibiotics or length of anti-
biotic therapy may be reduced in the case of bead implantation, 
without jeopardizing the control of infection. 

Late infections after total hip arthroplasty (THA) still remain 
a problem. Usually, a two-stage procedure is chosen for treat-
ment  of  infection,  whereby  either  a  resection  arthroplasty 
(Girdlestone procedure) is performed or an antibiotic-loaded 
spacer  is  inserted  (Hsieh  et  al.  2004, Anagnostakos  et  al. 
2006).
Recent reports have emphasized the importance of studying 
and understanding the elution of antibiotics from beads and 
spacers in such treatment procedures, in order to define the 
ideal moment for explantation of beads or spacer and to plan 
for reimplantation of the prosthesis (Bertazzonni Minelli et al. 
2004, Anagnostakos et al. 2006). The main advantage of these 
devices is that antibiotics are released from polymethylmeth-
acrylate (PMMA) in such a way that the local levels of anti-
biotic vastly exceed the minimum inhibitory or bactericidal 
concentrations  needed  to  treat  most  pathogenic  organisms, 
and that these levels are much higher than those achieved with 
parenteral therapy (Masri et al. 1998). Such high concentra-
tions are important, especially when gentamicin is used for 
impregnation of bone cement, because this aminoglycoside 
has a peak dose effect for bactericidal activity (McLean et al. 
1993). Isiklar et al. (1999) reported that 57 µg/mL vancomy-
cin could be measured in the drainage fluid from a vancomy-
cin-loaded hip spacer on the first postoperative day; however, 
later antibiotic release was not measured. Chohfi et al. (1998) 
used vancomycin-loaded cement for prosthesis fixation in pri-
mary THA and determined the concentrations released into 
the drainage fluid. Bactericidal concentrations could be mea-
sured over the first 4 days, but further concentrations were not 
known because all patients had had their drain removed at this 
time. In dogs, Adams et al. (1992) found detectable concentra-
tions of tobramycin and vancomycin from beads for 28 days. 
In rabbits, antibiotic-loaded cement pellets were found to elute 
antibiotics for up to 37 days (Chapman and Hadley 1976). 
Jenny et al. (1995) measured gentamicin concentrations in the 
drainage fluids of patients, but these were measured only on 
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We conducted a prospective study to evaluate the local anti-
biotic concentrations of gentamicin and vancomycin in patients 
undergoing two-stage exchange for infected THA: either by 
inserting antibiotic-loaded beads in the case of a Girdlestone 
procedure, or by implantation of an antibiotic-loaded spacer. 
Patients and methods
We studied 17 hip spacers (80 g PMMA, 1 g gentamicin, and 
4 g vancomycin) (Refobacin/Palacos: Merck, Darmstadt, Ger-
many; Vanco-cell: Cell-Pharm, Hannover, Germany) and 11 
chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) 
(Refobacin/Palacos, Vanco-cell) in 28 patients (spacer group: 
10 males and 7 females, mean age 69 (60–81) years; beads 
group: 6 males and 5 females, mean age 67 (41–76) years). 
In all cases, a causative pathogenic organism could be identi-
fied in the wound. In the spacer group, S. epidermidis was 
isolated 6 times, S. aureus 5 times, a methicillin-resistant S. 
aureus (MRSA) 3 times, and there were single isolates of P. 
mirabilis, E. faecalis, and E. faecium. In the beads group, S. 
epidermidis, S. aureus and MRSA were isolated 3 times each 
and there were single isolates of S. haemolyticus and E. fae-
calis. All organisms were sensitive to both gentamicin and 
vancomycin, except for the MRSA strains, which were gen-
tamicin-resistant. Both spacers (head diameter: 50 mm; stem 
length: 10 cm; surface area: 133 cm2) and chains (40 beads, 
total length: 93 cm; surface area: 160 cm2) were produced 
intraoperatively using molds, as reported previously (Kelm et 
al. 2004, Anagnostakos et al. 2005). In short, vancomycin was 
thoroughly mixed by hand into Refobacin/Palacos powder. 
After about 5 min of mixing, the cement’s liquid monomer 
was added. The cement dough was then poured into the two 
halves of the mold for the spacer/beads. The halves were then 
clamped together and, after about 15 min, they were opened 
and the molded spacer/chain was removed. 
In all cases, the primary indication for implantation of spac-
ers and beads was late infection after total hip arthroplasty. 
The choice of bead or spacer implantation was made accord-
ing to the general condition of each patient. If a patient was 
compromised by his general medical condition and thus could 
not afford a later prosthesis reimplantation, or was not willing 
to undergo a two-stage procedure, a Girdlestone arthroplasty 
with insertion of beads was performed. In each of these cases, 
half of the chain produced was inserted into the femur and the 
other half was inserted into the acetabular cavity. In the other 
cases, an articulated antibiotic-loaded spacer was implanted. 
All  spacers  were  fixed  to  the  femur  by  cementation  to  its 
proximal part. In all cases, the bone cement was loaded with 
gentamicin and vancomycin due to the broad antimicrobial 
spectrum and the known synergistic effect of these 2 agents 
regarding elution (Anagnostakos et al. 2006). 
Over the first postoperative days, a wound secretion speci-
men was taken from the redon drainage bottle every 24 h via 
the drainages placed directly at the head of the spacers or near 
the beads (Figure 1). The redons were left in situ until less than 
50 mL/day was produced. For the spacers, redons were left in 
situ for a maximum of 7 days, and for 13 days in the case of 
beads. The drainage system was changed daily. A systemic 
antibiotic was given in each case according to antibiogram, 
but no patients were given gentamicin or vancomycin intra-
venously in order to ensure that the concentrations measured 
in the drainage fluid could only be attributed to elution from 
the cement.
A fluorescence polarization immunoassay (FPIA) (Abbot, 
Wiesbaden, Germany) was used to determine the concentra-
tions  of  gentamicin  and  vancomycin  released.  The  lowest 
measurable concentration of drug was 0.27 µg/mL for genta-
micin and 2.0 µg/mL for vancomycin. 
Results
Both agents showed similar release characteristics over the 
first postoperative days (Figures 2 and 3). In the beads group, 
mean gentamicin concentration was higher than that of van-
comycin on day 1 (116 (12–371) µg/mL vs. 80 (21–198) µg/
mL, respectively), whereas in the days that followed the mean 
concentration of vancomycin was always higher than that of 
gentamicin. In the spacer group, mean vancomycin concentra-
Figure 1. Gentamicin- and vancomycin-impregnated spacer in situ. The 
elution of antibiotics was determined using the wound drainage placed 
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tions were higher than those of gentamicin on day 1 (37 (3.3–
72) µg/mL vs. 21.1 (0.7–39) µg/mL) and remained higher over 
the entire length of the measurement period.
After reaching their highest concentrations on day 1, the 
elution of both antibiotics decayed constantly at a similar rate 
over the following days. . The last concentrations to be deter-
mined were 3.7 µg/mL gentamicin and 23 µg/mL vancomycin 
in the beads group after 13 days, and 1.9 µg/mL gentamicin 
and 6.6 µg/mL vancomycin in the spacer group after 7 days. 
Between the fifth and the seventh day, we found an intermit-
tent increase in the elution of vancomycin from both beads 
and spacers and of gentamicin from spacers. There was a sub-
stantial degree of inter-subject variability with regard to the 
peak amounts released (Figures 4 and 5). 
No renal or hepatic dysfunction was observed in any of the 
cases.
The total amount of gentamicin and vancomycin released 
from beads and spacers was not determined.
Figure 5. The release of antibiotic from beads also showed substantial 
inter-individual variability for both agents regarding the peak amounts 
of antibiotic released during the first postoperative days.
Figure 4. The elution from the spacers showed substantial inter-indi-
vidual variability in the peak amounts of antibiotic released during the 
first postoperative days.
Figure 3. Elution of gentamicin and vancomycin from spacers over the 
first 7 postoperative days. Mean and extreme values (minimum-maxi-
mum) are shown for each day.
Figure 2. Elution of gentamicin and vancomycin from beads over the 
first 13 postoperative days. Mean and extreme values (minimum-maxi-
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Discussion
Since the introduction of antibiotic-loaded bone cement by 
Buchholz and Engelbrecht in the early 1970s (Buchholz and 
Engelbrecht 1970), antibiotic-impregnated bone cement has 
been  used  in  the  prophylaxis  and  treatment  of  orthopedic 
infections by means of spacers or beads (Klemm 1976, Anag-
nostakos et al. 2006).
Due to the increasing emergence of multiresistant patho-
genic organisms over the past few years, cement media loaded 
with two different antibiotics are being used more frequently 
in the treatment of orthopedic infections (Masri et al. 1998, 
Anagnostakos et al. 2006). It is known that there is a syner-
gistic  effect  between  aminoglycosides  and  glycopeptides 
with regard to antimicrobial properties and pharmacokinet-
ics of bone cement (Anagnostakos et al. 2005), but few data 
are available on the precise nature of the interactions between 
these substances in vivo. Klekamp et al. (1999) studied the 
release of tobramycin and vancomycin from Simplex and Pal-
acos cement in vitro and found that the release of tobramycin 
was compromised by the presence of vancomycin, whereas 
the release of vancomycin was not compromised by the pres-
ence of tobramycin. Another in vitro study by Penner et al. 
(1996) demonstrated that the combination of both antibiotics 
in PMMA enhances the release of tobramycin by 68% and 
of vancomycin by 103% in comparison to controls contain-
ing tobramycin or vancomycin alone. In vivo studies of tobra-
mycin- and vancomycin-impregnated hip and knee spacers 
showed superior elution for tobramycin than for vancomycin, 
but the elution of vancomycin was enhanced by the presence 
of tobramycin (Masri et al. 1998).
We have not found any previous studies describing mea-
surement of antibiotic elution from PMMA on a daily basis 
beyond the first 2–3 postoperative days. The greater amount 
of vancomycin incorporated into PMMA should explain our 
findings of higher concentrations released over the early post-
operative period, except for the first day. Despite the fact that 
the beads were impregnated with half of the amount of antibi-
otic that the spacers were, in the first days the beads released 
greater amounts of both agents due to their larger surface area 
(Anagnostakos et al. 2006). Although the difference between 
the surface area of the chains and that of the spacer is not 
appreciable, we would explain this discrepancy by the fact that 
most of the antibiotic-releasing surface of each spacer is cov-
ered by the proximal part of the femur where the antibiotics 
cannot be washed off from the surface as easily as in the case 
of beads. 
Hsieh et al. (2006) reported recently on the elution of van-
comycin and aztreonam from hip spacers. Peak concentrations 
of vancomycin initially were 1,538 µg/mL and they decreased 
over 7 days to a mean value of 519 µg/mL. However, the 
spacer was loaded with 4 g vancomycin per 40 g PMMA 
whereas ours contained only 2 g vancomycin per 40 g PMMA. 
Furthermore, aztreonam may have a different influence on the 
pharmacokinetics of vancomycin than gentamicin has; thus, 
another synergistic effect might result.
Nelson et al. (1994) studied the residual elution properties 
of gentamicin-loaded beads in vitro after retrieval. They found 
that beads that had been implanted for less than 10 weeks 
released significantly higher levels of antibiotics than beads 
that had been implanted for more than 14 weeks. Interest-
ingly, there also exist in vitro findings on explanted spacers 
that indicate different residual capacities with regard to anti-
biotic release and antimicrobial properties independently of 
the  implantation  period  (Bertazzonni  Minelli  et.  al.  2004). 
Although the exact cause of this discrepancy between pub-
lished data is unclear, it is possible that individual variations in 
the local perfusion during implantation, anatomical variations 
and changes in the cement surface due to coverage, e.g. from 
scar tissue, may play a role. The tissue penetration and absorp-
tion of both agents in vivo might also be an issue.
Our  results  also  show  high  inter-subject  variability  with 
regard to the peak concentrations of antibiotic measured. For 
example, in the beads group the mean gentamicin concentra-
tion was 116 µg/mL on day 1, while the maximum concen-
tration measured was at 370 µg/mL. Moreover, peaks were 
measured between the fifth and seventh day. This discrepancy 
may be attributable to several factors such as local blood per-
fusion or pH value of the tissues; however, we believe that 
the manual incorporation of the vancomycin into the cement 
powder is the main parameter responsible for the variability. 
This inhomogenity of antibiotic elution has been seen by the 
authors in in vitro studies (Anagnostakos et al. 2005) and can 
often be expected with the use of non-commercially manu-
factured  antibiotic-loaded  cement  media.  Furthermore,  this 
inhomogeneity  combined  with  the  above-listed  inter-indi-
vidual factors makes it difficult to assess with any accuracy 
the total amount of antibiotic released from spacers in vivo. 
Bertazzonni Minelli et al. (2004) have shown that the release 
of antibiotic is still irregular even 3–4 months after hip spacer 
implantation, independently of the implantation time.
 The fact that a sufficient amount of antibiotic release from 
beads lasts longer than from spacers emphasizes the impor-
tance of systemic antibiotics, given as a complement to the 
spacer implantation, over the first 4–6 postoperative weeks in 
order to avoid not only spread of the infection, but also per-
sistence of the infection locally. Perhaps in the case of a bead 
implantation, the dose of the intravenous antibiotic could be 
reduced over the first 2 postoperative weeks due to sufficiency 
of  local  antibiotic  therapy,  but  after  this  time  period  a  re-
adjustment of the dose might be necessary in order to prevent 
the emergence of resistant bacterial strains—since the local 
antibiotic concentrations decrease over time. Future clinical 
studies should clarify this issue. Some antibiotics require mea-
surement of peak and trough serum levels during therapy, and 
the dose is usually adjusted based on those levels. Generally, 
in the case of late infections where the source of the infection 
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not only for treatment of the joint infection, but also for treat-
ment of the primary source of the infection and to avoid any 
other manifestations of infection. However, in the presence of 
antibiotic-loaded cement devices, complications might occur 
despite the fact that such media are considered to be safe (Sal-
vati et al. 1986). Side effects are probably the result of systemic 
antibiotic administration along with local therapy. Koo et al. 
(2001) described the occurrence of a transient liver dysfunc-
tion and bone marrow depression following the simultaneous 
implantation of an antibiotic-loaded spacer and intravenous 
treatment with antibiotics. Patrick et al. (2006) described an 
acute renal failure after the use of vancomycin- and tobramy-
cin-loaded spacers in total hip arthroplasty.
  In  summary,  gentamicin-  and  vancomycin-loaded  beads 
and hip spacers appear to be capable of releasing sufficient 
concentrations over the first 7–13 postoperative days in vivo. 
Future studies will be required to determine whether this also 
applies to other antibiotics and other amounts of antibiotic 
incorporated into PMMA. We recommend the use of systemic 
antibiotics for at least the first 4 postoperative weeks, to ensure 
eradication of the infection and to avoid re-infections or per-
sistent infections, especially since both beads and spacers have 
shown an appreciable amount of inter-individual variability 
regarding peak concentrations of antibiotic release.
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